Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|
| Total reported revenue | 10.8B | 10.1B | 9.3B | 9.4B |
| Cost of revenue | 1.9B | 1.9B | 1.7B | 1.7B |
| Gross profit | 8.8B | 8.2B | 7.6B | 7.6B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 225.0M | 242.5M | 190.5M | 255.9M |
| Other operating expenses | 275.6M | 252.9M | 228.6M | 213.8M |
| Operating income | 5.3B | 4.7B | 4.4B | 4.6B |
| Non operating interest income | ||||
| Income | 119.3M | 109.7M | 362.9M | 355.8M |
| Expense | 3.5B | 3.4B | 3.1B | 2.9B |
| Other income expense | — | — | — | — |
| Pretax income | -3.0B | 1.8B | 2.0B | 3.3B |
| Tax provision | -524.8M | 240.2M | 217.0M | 448.7M |
| Net income | -2.4B | 1.6B | 1.8B | 2.8B |
| Basic EPS | — | 1.7 | 1.9 | — |
| Diluted EPS | — | 1.7 | 1.9 | — |
| Basic average shares | — | 947.9M | 947.9M | — |
| Diluted average shares | — | 947.9M | 947.9M | — |
| EBITDA | 8.7B | 8.2B | 7.7B | 7.8B |
| Net income from continuing op. | -3.3B | 1.5B | 1.8B | 3.0B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | 0 | 0 | 0 | 0 |